HOME > 홍보/투자정보 > 산업동향
노바티스, AAV9 유전자치료제 확보..'AveXis 87억弗 인수'
ViroMed
2018/04/25
www.biospectator.com/view/news_view.php?varAtcId=5303

http://www.biospectator.com/view/news_view.php?varAtcId=5303